Benign Migratory Glossitis Associated With Antiangiogenic Drugs

Instituto do Cancer do Estado de São Paulo

Status: Completed

Conditions: Geographic Tongue; Cancer

Treatments: Other: Clinical evaluation

Study type: Observational

Funder types: Other

Identifiers

NCT06988865

Ethics Committee : 6.901.573

Details and patient eligibility

About

Oral clinical descriptions related to adverse events in patients treated with those elective multi-targeted receptor tyrosine kinase inhibitors and a recombinant humanised monoclonal antibody

Full description

Electronical medical and dental records, high-resolution digital photograph were reviewed. Demographic data, medical background, clinical and laboratory information were recorded for each individual case.

Enrollment: 8 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patient's charts which underwent antiangiogenic targeted drugs

Exclusion criteria

• chemoterapy without angiogenesis inhibitors

Trial design

8 participants in 1 patient group

angiogenesis inhibitors

Description:

Oral clinical manifestation

Treatment:

Other: Clinical evaluation